WallStreetZenWallStreetZen

NASDAQ: ABCL
Abcellera Biologics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ABCL

Based on 1 analyst offering 12 month price targets for Abcellera Biologics Inc.
Min Forecast
$5.00+73.01%
Avg Forecast
$5.00+73.01%
Max Forecast
$5.00+73.01%

Should I buy or sell ABCL stock?

Based on 1 analyst offering ratings for Abcellera Biologics Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ABCL stock forecasts and price targets.

ABCL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-07-11

1 of 1

ABCL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ABCL$2.89$5.00+73.01%Strong Buy
NGNE$66.00$56.00-15.15%Buy
RAPP$23.62$37.33+58.06%Strong Buy
SANA$3.76$13.00+245.74%Strong Buy
TYRA$16.42$31.40+91.23%Strong Buy

Abcellera Biologics Stock Forecast FAQ

Is Abcellera Biologics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ABCL) stock is to Strong Buy ABCL stock.

Out of 1 analyst, 1 (100%) are recommending ABCL as a Strong Buy, 0 (0%) are recommending ABCL as a Buy, 0 (0%) are recommending ABCL as a Hold, 0 (0%) are recommending ABCL as a Sell, and 0 (0%) are recommending ABCL as a Strong Sell.

If you're new to stock investing, here's how to buy Abcellera Biologics stock.

What is ABCL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ABCL price target, the average ABCL price target is $5.00, with the highest ABCL stock price forecast at $5.00 and the lowest ABCL stock price forecast at $5.00.

The Wall Street analyst predicted that Abcellera Biologics's share price could reach $5.00 by Jul 11, 2025. The average Abcellera Biologics stock price prediction forecasts a potential upside of 73.01% from the current ABCL share price of $2.89.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.